Back to Authors

Peng, Andrew

Mayo Clinic

9Kite, a Gilead Company, Santa Monica, CA

Citations 1

ZUMA-19: A Phase 1/2 Study of Axicabtagene Ciloleucel Plus Lenzilumab in Patients With Relapsed or Refractory Large B-Cell Lymphoma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10318-10320

10.1182/blood-2022-167688